Skip to content

GLOBUS MEDICAL INC

GMED · XNYS

CIK 1237831fmd_00ZPCT4AK8PHGS4FT50XQHZFY5Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2026, 64 periods

Latest annual · FY2025

Millions
Total revenues
2,939
Gross profit
1,981
Operating income
480
Net income
538
Free cash flow
589

Latest quarter · Q3 FY2026

Millions
Total revenues
764
Gross profit
531
Operating income
178
Net income
141
Free cash flow
225

Daily close · GMEDIEX trades only

Nov 13, 2025 to Nov 11, 2026 · 250 sessions

75.37 USD

708090100Nov 13, 2025May 14, 2026Nov 11, 2026Vol

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
+42.2%
Revenue, 5 yearsFY2020 to FY2025
+30.1%
Net income, 5 yearsFY2020 to FY2025
+39.4%

GLOBUS MEDICAL INC (GMED) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$2.9 billion$2.5 billion+16.7%10-K 2026-02-24 · proof
Gross profit$2 billion$1.5 billion+33.5%10-K 2026-02-24 · proof
Operating income$479.8 million$166 million+189.1%10-K 2026-02-24 · proof
Net income$537.9 million$103 million+422.3%10-K 2026-02-24 · proof
Cash from operating activities$753.4 million$520.6 million+44.7%10-K 2026-02-24 · proof
Free cash flow$588.8 million$405.2 million+45.3%10-K 2026-02-24 · proof
Total assets$5.3 billion$5.3 billion+1%10-K 2026-02-24 · proof
Total liabilities$729.5 million$1.1 billion-32.1%10-K 2026-02-24 · proof
Cash and cash equivalents$526.2 million$784.4 million-32.9%10-K 2026-02-24 · proof
What was GLOBUS MEDICAL INC (GMED)'s revenue in fiscal 2025?
GLOBUS MEDICAL INC (GMED) reported revenue of $2.9 billion for fiscal 2025 (the year ended Dec 31, 2025), against $2.5 billion the year before (+16.7%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was GLOBUS MEDICAL INC (GMED)'s gross profit in fiscal 2025?
GLOBUS MEDICAL INC (GMED) reported gross profit of $2 billion for fiscal 2025 (the year ended Dec 31, 2025), against $1.5 billion the year before (+33.5%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was GLOBUS MEDICAL INC (GMED)'s operating income in fiscal 2025?
GLOBUS MEDICAL INC (GMED) reported operating income of $479.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $166 million the year before (+189.1%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was GLOBUS MEDICAL INC (GMED)'s net income in fiscal 2025?
GLOBUS MEDICAL INC (GMED) reported net income of $537.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $103 million the year before (+422.3%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was GLOBUS MEDICAL INC (GMED)'s cash from operating activities in fiscal 2025?
GLOBUS MEDICAL INC (GMED) reported cash from operating activities of $753.4 million for fiscal 2025 (the year ended Dec 31, 2025), against $520.6 million the year before (+44.7%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was GLOBUS MEDICAL INC (GMED)'s free cash flow in fiscal 2025?
GLOBUS MEDICAL INC (GMED) reported free cash flow of $588.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $405.2 million the year before (+45.3%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What are GLOBUS MEDICAL INC (GMED)'s total assets?
As of Dec 31, 2025, GLOBUS MEDICAL INC (GMED) reported total assets of $5.3 billion, against $5.3 billion a year earlier (+1%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What are GLOBUS MEDICAL INC (GMED)'s total liabilities?
As of Dec 31, 2025, GLOBUS MEDICAL INC (GMED) reported total liabilities of $729.5 million, against $1.1 billion a year earlier (-32.1%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What are GLOBUS MEDICAL INC (GMED)'s cash and cash equivalents?
As of Dec 31, 2025, GLOBUS MEDICAL INC (GMED) reported cash and cash equivalents of $526.2 million, against $784.4 million a year earlier (-32.9%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:GMED&period_type=annual&limit=5"

Information only, not investment advice.

GMED · FinancialMD